A biotech like Mesoblast has a long hard road to market.Following this stock just shows how really hard it is to get there.Particualary lately with issues such as Teva pulling out and the Nasdaq listing.But Mesoblast are just moving forward relentlessly to there ultimate goal and success.
A biotech like Mesoblast has a long hard road to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.033(3.16%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $4.019M | 3.767M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 24496 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 16691 | 9 |
View Market Depth
| Last trade - 12.54pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |